“Vasomotor Symptoms Market” report has been added to DelveInsight
The Vasomotor Symptoms Market report on gives adjusted data which has the mix of the past, current and future information that assists with understanding the Global Vasomotor Symptoms Market better. As such, it is a thorough rundown of the multitude of significant variables that are identified with expanding request development with regards to the market across the world. The report likewise gives subtleties of future prospects which have the most recent patterns that are to be found in the coming a long time in this focused on Vasomotor Symptoms Market
Request for free sample copy of Vasomotor Symptoms Market Report- https://www.delveinsight.com/sample-request/vasomotor-symptoms-market
About Vasomotor Symptoms
Vasomotor symptoms are the most commonly reported menopausal symptoms. These symptoms, often called hot flashes, are characterized by a sudden increase of blood flow, often to the face, neck, and chest that causes the sensation of extreme heat and profuse sweating. When symptoms occur at night they are called “night sweats” and can cause significant sleep disturbances. Episodes of vasomotor symptoms can last 1 to 5 minutes and can be associated with perspiration, flushing, chills, anxiety, and even heart palpitations.
Vasomotor Symptoms Geography Covered
Vasomotor Symptoms Key Players
Vasomotor Symptoms Market Report
VMS are a form of temperature dysfunction that occurs due to changes in gonadal hormones. Normally, core body temperature (CBT) remains within a specific range, oscillating with daily circadian rhythms. Physiological processes that conserve and dissipate heat are responsible for maintaining CBT, and tight regulation is important for maintenance of optimal internal organ function. Disruption of this tightly controlled temperature circuit results in exaggerated heat-loss responses and presents as VMS. The mechanistic role related to changes in gonadal hormones associated with VMS is not understood.
Vasomotor Symptoms Treatment Market
Prescription systemic estrogen-containing products remain the therapeutic standard for moderate to severe menopause-related hot flashes. Recommended options for women with concerns or contraindications relating to estrogen-containing treatments include prescription progestogens, venlafaxine, paroxetine, fluoxetine, or gabapentin. Although paroxetine (Paxil) is the only nonhormonal medication approved by the US FDA for this indication.
Vasomotor Symptoms Market: Report Highlights
Following is the Table of content of Vasomotor Symptoms market report
1. Key Insights
2. Vasomotor Symptoms (Hot Flashes/Night Sweats): Market Overview at a Glance
3. Executive summary
4. Organizations
5. Epidemiology and Market Methodology
6. Vasomotor Symptoms (VMS) associated with menopause: Disease Background and Overview
7. Vasomotor Symptoms Epidemiology and Patient Population
8. Total Prevalent cases of Vasomotor Symptoms (Hot Flashes/Night Sweats) in Post-menopause in 7MM
9. Country Wise-Epidemiology of Hot Flashes Associated with Post-menopause
10. Vasomotor Symptoms Treatment Algorithm, Current Treatment, and Medical Practices
11. Unmet Needs
12. Marketed drugs by class
13. Vasomotor Symptoms Emerging Therapies
14. Hot Flashes: 7 Major Market Analysis
15. Seven Major Market Outlook
16. Market Drivers
17. Market Barriers
18. SWOT
19. Case Studies
20. KOL Views
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
24. About DelveInsight
What are the reasons to buy this report?
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/